Advertisement

More articles from Companion Diagnostics and Cancer Biomarkers

  • Plasma Metabolites Predict Response to MEK Inhibitor
    Joo Ern Ang, Akos Pal, Yasmin J. Asad, Alan T. Henley, Melanie Valenti, Gary Box, Alexis de haven Brandon, Victoria L. Revell, Debra J. Skene, Miro Venturi, Ruediger Rueger, Valerie Meresse, Suzanne A. Eccles, Johann S. de Bono, Stanley B. Kaye, Paul Workman, Udai Banerji, Florence I. Raynaud
    Molecular Cancer Therapeutics Oct 2017, 16 (10) 2315-2323; DOI: 10.1158/1535-7163.MCT-16-0881
  • Targets of Combined mTOR/HDAC Inhibition
    John K. Simmons, Aleksandra M. Michalowski, Benjamin J. Gamache, Wendy DuBois, Jyoti Patel, Ke Zhang, Joy Gary, Shuling Zhang, Snehal Gaikwad, Daniel Connors, Nicholas Watson, Elena Leon, Jin-Qiu Chen, W. Michael Kuehl, Maxwell P. Lee, Adriana Zingone, Ola Landgren, Peter Ordentlich, Jing Huang, Beverly A. Mock
    Molecular Cancer Therapeutics Sep 2017, 16 (9) 2008-2021; DOI: 10.1158/1535-7163.MCT-17-0171
  • RAS and BRAF genotyping for Anti-EGFR treatment in mCRC
    Cristina Santos, Daniel Azuara, Rocio Garcia-Carbonero, Pilar Garcia Alfonso, Alfredo Carrato, Mª Elena Elez, Auxiliadora Gomez, Ferran Losa, Clara Montagut, Bartomeu Massuti, Valenti Navarro, Mar Varela, Adriana Lopez-Doriga, Victor Moreno, Manuel Valladares, Jose Luis Manzano, Jose Maria Vieitez, Enrique Aranda, Xavier Sanjuan, Josep Tabernero, Gabriel Capella, Ramon Salazar
    Molecular Cancer Therapeutics Sep 2017, 16 (9) 1999-2007; DOI: 10.1158/1535-7163.MCT-17-0153
  • Predictive and Pharmacodynamic Biomarkers for Erdafitinib
    Jayaprakash D. Karkera, Gabriela Martinez Cardona, Katherine Bell, Dana Gaffney, Joseph C. Portale, Ademi Santiago-Walker, Christopher H. Moy, Peter King, Michael Sharp, Rastislav Bahleda, Feng R. Luo, John D. Alvarez, Matthew V. Lorenzi, Suso J. Platero
    Molecular Cancer Therapeutics Aug 2017, 16 (8) 1717-1726; DOI: 10.1158/1535-7163.MCT-16-0518
  • G9a Modulates GCLC Expression and Chemoresistance
    Chia-Wen Liu, Kuo-Tai Hua, Kai-Chun Li, Hsiang-Fong Kao, Ruey-Long Hong, Jenq-Yuh Ko, Michael Hsiao, Min-Liang Kuo, Ching-Ting Tan
    Molecular Cancer Therapeutics Jul 2017, 16 (7) 1421-1434; DOI: 10.1158/1535-7163.MCT-16-0567-T
  • Concordance of Tissue and Liquid Biopsies in Breast Cancer
    Young Kwang Chae, Andrew A. Davis, Sarika Jain, Cesar Santa-Maria, Lisa Flaum, Nike Beaubier, Leonidas C. Platanias, William Gradishar, Francis J. Giles, Massimo Cristofanilli
    Molecular Cancer Therapeutics Jul 2017, 16 (7) 1412-1420; DOI: 10.1158/1535-7163.MCT-17-0061
  • Role of PMP22 in Gastric Cancer
    Wangyu Cai, Gang Chen, Qicong Luo, Jun Liu, Xiaofeng Guo, Tian Zhang, Fei Ma, Liang Yuan, Boan Li, Jianchun Cai
    Molecular Cancer Therapeutics Jun 2017, 16 (6) 1187-1198; DOI: 10.1158/1535-7163.MCT-16-0750
  • Cell-Free DNA from Ascites and Pleural Effusions
    Hatim Husain, David Nykin, Nam Bui, Daniel Quan, German Gomez, Brian Woodward, Sumathi Venkatapathy, Radha Duttagupta, Eric Fung, Scott M. Lippman, Razelle Kurzrock
    Molecular Cancer Therapeutics May 2017, 16 (5) 948-955; DOI: 10.1158/1535-7163.MCT-16-0436
  • MALAT1 and Colorectal Cancer Chemotherapy
    Peilong Li, Xin Zhang, Haiyan Wang, Lili Wang, Tong Liu, Lutao Du, Yongmei Yang, Chuanxin Wang
    Molecular Cancer Therapeutics Apr 2017, 16 (4) 739-751; DOI: 10.1158/1535-7163.MCT-16-0591
  • APC as a Predictive Biomarker in Colorectal Cancer Therapy
    Noritaka Tanaka, Tetsuo Mashima, Anna Mizutani, Ayana Sato, Aki Aoyama, Bo Gong, Haruka Yoshida, Yukiko Muramatsu, Kento Nakata, Masaaki Matsuura, Ryohei Katayama, Satoshi Nagayama, Naoya Fujita, Yoshikazu Sugimoto, Hiroyuki Seimiya
    Molecular Cancer Therapeutics Apr 2017, 16 (4) 752-762; DOI: 10.1158/1535-7163.MCT-16-0578

Pages